Episode Description:

Welcome to the Lichen Sclerosus Podcast brought to you by the Lichen Sclerosus Support Network. I'm your host, Kathy, and today we’re excited to bring you a conversation with an amazing researcher, Leia Mitchell. If you’ve listened before, you might recognize her from past episodes. This time, we’re diving into a new possible treatment for Lichen Sclerosus.

What You’ll Learn in This Episode:

• Insights into two groundbreaking studies on silicone-based treatments for Lichen Sclerosus.
• The science behind silicone’s effects on collagen production and skin rejuvenation.
• What makes this new treatment non-steroidal and why that matters.
• Eligibility requirements and what participation in the study entails.

Special Guest:

Meet Leia Mitchell, a passionate and knowledgeable physician assistant with extensive experience in Lichen Sclerosus treatment and clinical research. Her expertise and dedication make her a valuable voice in the LS space.

Key Moments:

• 1:49 – Discussion of two studies: one completed and one actively recruiting participants in Florida, DC, and NYC.
• 3:35 – Leia explains how silicone aids collagen production and benefits skin conditions, including burn victims.
• 5:21 – Application process: The silicone gel is easy to use—dab and rub gently over affected areas.
• 6:26 – Leia highlights the need for effective LS treatments and shares how she became involved in the study.
• 7:14 – The appeal of non-steroidal treatments and how Leia encountered this promising solution.
• 9:24 – Study requirements: participants must have an active LS diagnosis, abstain from steroids or other topicals, and undergo pre- and post-study biopsies.
• 13:10 – The study is initially limited to five participants, but a larger trial may follow pending positive results.
• 15:09 – Leia shares her excitement for the study’s potential outcomes and outlines the 10-week process, which includes subjective results announced after publication.
• 34:01 – Leia discusses the goal of FDA approval to make the treatment accessible and affordable for patients through insurance coverage.

Connect with Us:

Visit the Lichen Sclerosus Support Network for more resources: lssupportnetwork.org

Get more information on the study at https://clinicaltrials.gov/study/NCT06662942?cond=stratamgt&rank=2

or email the CVVD at [email protected]